Deepinder Goyal's ₹85,000 wearable device, Temple, is facing questions from doctors over its scientific credibility. While the former Eternal CEO maintains that the product is a fitness and AI device rather than a medical device, doctors argue that its claims about measuring blood flow to the brain have not been adequately established. The controversy has also drawn attention to the product's changing positioning and Goyal's combative responses to criticism.
\n\nTemple began as an experiment to measure blood flow to the brain and understand ageing. It was subsequently associated with a new biomarker called entropy, before being positioned as a fitness tracker. Goyal has more recently described it as an AI-powered personal companion that uses vibrations to capture the wearer's speech, calling it "humanity's last personal device".
\n\nPre-orders opened on November 1, but questions remain about what the device actually measures, how reliable its readings are and what evidence supports its claims.
\n\nIn an interview with CNBC-TV18, Harish Bijoor, Founder of Harish Bijoor Consults; Dr Sanjeev Bagai, Padma Shri awardee and Chairman of Nephron Clinics; and Prakash Dadlani, Co-Founder of Topsail Appliances, discussed the scientific, business and communication challenges facing Temple.
\n\nWhat does Temple actually measure, and why are doctors questioning…
Original source: https://www.cnbctv18.com/technology/
